Europe — EMA
Palexia (Tapentadol)
Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients.
International sale not permitted. Listed for the domestic market and B2B only.
Request sourcing
What is Tapentadol?
Tapentadol, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe acute pain in adult patients. GNH USA supplies Palexia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Tapentadol used for?
Tapentadol is an opioid analgesic that acts on the central nervous system to relieve pain. It is used in several clinical situations: - Acute postoperative pain: Provides effective relief following surgical procedures. - Chronic musculoskeletal pain: Helps manage persistent pain from conditions such as osteoarthritis. - Cancer‑related pain: Used as part of a multimodal regimen for cancer pain management.
What are the side effects of Tapentadol?
Tapentadol may cause a range of adverse reactions, most of which are dose‑dependent and reversible.
Common Side Effects: - Nausea: Mild to moderate upset stomach. - Dizziness: Light‑headed feeling, especially when standing quickly. - Constipation: Reduced bowel movements, common with opioid therapy. - Headache: Transient cranial discomfort. - Somnolence: Feeling unusually sleepy. - Dry mouth: Reduced salivation.
Serious or Rare Side Effects: - Respiratory depression: Shallow or slowed breathing requiring medical attention. - Seizures: Uncontrolled electrical activity in the brain. - Severe hypotension: Markedly low blood pressure. - Allergic reactions: Rash, itching, swelling, or anaphylaxis. - Dependence or abuse potential: Risk of developing opioid use disorder. - adrenal insufficiency: Hormonal deficiency affecting stress response.
What precautions apply to Tapentadol?
When prescribing Tapentadol, clinicians should consider several safety measures: - Assess patient history: Review the risk for addiction and substance abuse. - Monitor for respiratory depression especially at higher doses. - Evaluate renal function to adjust dosing if necessary. - Caution in elder ‑ - Elder t t t and the ... ... ... ... \n- t t t t ... t ... t... \n--- ewline --- \n --- ... ... ewline ewline \n t t " " ewline ight
Store at t t.
--- --- \
What does Tapentadol interact with?
The ",



